RFB, BO, CC, VE, PCQ, LP, HW, VN, HS, CMM, DS, HP, JMD, DCS, and MEP acquired, analyzed, or interpreted data
Liraglutide (Saxenda) At the highest recommended dose of 3 mg, Liraglutide lowers blood pressure an average of 3.2 mmHg, with no apparent effect on diastolic blood pressure
Observational studies using real-world data have generally corroborated these findings
This treatment encourages: Collagen production Elastin support Improved skin texture Firmer-looking skin Healthier skin density Better product penetration Smoother crepey skin appearance Many clients begin noticing improvements in: Skin firmness Overall glow Texture Fine lines Skin resilience With continued improvement over several months as collagen remodeling occurs
Acta Diabetol 61 , 941950 (2024)